PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectations

Published:2021-09 Issue: Volume:99 Page:102255
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Vanacker Hélène,Harter Philipp,Labidi-Galy Sana Intidhar,Banerjee Susana,Oaknin Ana,Lorusso Domenica,Ray-Coquard Isabelle

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference100 articles.

1. Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C, et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24:vi24–32. https://doi.org/10.1093/annonc/mdt333.

2. Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial;Pujade-Lauraine;J Clin Oncol,2014

3. Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients;Wagner;Br J Cancer,2012

4. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary;Ahmed;J Pathol,2010

5. The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011;474:609–15. https://doi.org/10.1038/nature10166.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tandem mass tag-based quantitative proteomic analysis of metformin’s inhibitory effects on ovarian cancer cells;Journal of Cancer Research and Therapeutics;2024-08

2. Nucleolar Localization of the RNA Helicase DDX21 Predicts Survival Outcomes in Gynecologic Cancers;Cancer Research Communications;2024-06-13

3. Review of the Potential Role of Ascorbate in the Prevention and Treatment of Gynecological Cancers;Antioxidants;2024-05-19

4. Transcriptome analysis reveals the clinical significance of CXCL13 in Pan-Gyn tumors;Journal of Cancer Research and Clinical Oncology;2024-03-09

5. How BRCA and homologous recombination deficiency change therapeutic strategies in ovarian cancer: a review of literature;Frontiers in Oncology;2024-03-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3